European Commission Agrees to Purchase 300 Million Coronavirus Vaccine Doses

France based Sanofi and GSK announced they have finalized an advanced purchase agreement with the European Commission for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved. This final agreement confirms the announcement made on July 31, 2020, and marks a key milestone in protecting European populations against COVID-19.

Previously, the companies announced the launch of a Phase 1/2 clinical study on September 3rd. And stated a 'Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021.'